Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunghoon Kim

Showing results (441-450 of 535) with videos related to

Pageof 54
Sort By:
Journal of Molecular Histology|August 31, 2013
A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D)Ah Jung Seo, Youn Ho Shin, Seo Jin Lee, et al.
Molecular Neurobiology|October 15, 2022
Anti-apoptotic Splicing Variant of AIMP2 Recover Mutant SOD1-Induced Neuronal Cell DeathMyung Geun Kook, Mi Ran Byun, Soo Min Lee, et al.
Nature Communications|November 8, 2023
Unveiling the double-peak structure of quantum oscillations in the specific heatZhuo Yang, Benoît Fauqué, Toshihiro Nomura, et al.
The Journal of Biological Chemistry|March 18, 2008
Determination of three-dimensional structure and residues of the novel tumor suppressor AIMP3/p18 required for the interaction with ATMKyung-Jin Kim, Min Chul Park, So Jung Choi, et al.
Journal of Medicinal Chemistry|April 22, 2020
Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer TherapyAneesh Sivaraman, Dae Gyu Kim, Deepak Bhattarai, et al.
Journal of Clinical Medicine|February 21, 2020
Plasma Lysyl-tRNA Synthetase 1 (KARS1) as a Novel Diagnostic and Monitoring Biomarker for Colorectal CancerJi Hun Suh, Min Chul Park, Peter C Goughnour, et al.
JAMA Surgery|September 6, 2023
Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant ChemotherapyJung-Yun Lee, Yong Jae Lee, Joo-Hyuk Son, et al.
Journal of Molecular Cell Biology|April 26, 2012
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancerJin Woo Choi, Jeong-Won Lee, Jun Ki Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesisMin Chul Park, Taehee Kang, Da Jin, et al.
International Journal of Cancer|August 21, 2023
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045Yoo-Na Kim, Je-Gun Joung, Eunhyang Park, et al.
Pageof 54

Showing results (441-450 of 535) with videos related to

Sort By:
Pageof 54
Journal of Molecular Histology|August 31, 2013
A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D)Ah Jung Seo, Youn Ho Shin, Seo Jin Lee, et al.
Molecular Neurobiology|October 15, 2022
Anti-apoptotic Splicing Variant of AIMP2 Recover Mutant SOD1-Induced Neuronal Cell DeathMyung Geun Kook, Mi Ran Byun, Soo Min Lee, et al.
Nature Communications|November 8, 2023
Unveiling the double-peak structure of quantum oscillations in the specific heatZhuo Yang, Benoît Fauqué, Toshihiro Nomura, et al.
The Journal of Biological Chemistry|March 18, 2008
Determination of three-dimensional structure and residues of the novel tumor suppressor AIMP3/p18 required for the interaction with ATMKyung-Jin Kim, Min Chul Park, So Jung Choi, et al.
Journal of Medicinal Chemistry|April 22, 2020
Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer TherapyAneesh Sivaraman, Dae Gyu Kim, Deepak Bhattarai, et al.
Journal of Clinical Medicine|February 21, 2020
Plasma Lysyl-tRNA Synthetase 1 (KARS1) as a Novel Diagnostic and Monitoring Biomarker for Colorectal CancerJi Hun Suh, Min Chul Park, Peter C Goughnour, et al.
JAMA Surgery|September 6, 2023
Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant ChemotherapyJung-Yun Lee, Yong Jae Lee, Joo-Hyuk Son, et al.
Journal of Molecular Cell Biology|April 26, 2012
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancerJin Woo Choi, Jeong-Won Lee, Jun Ki Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesisMin Chul Park, Taehee Kang, Da Jin, et al.
International Journal of Cancer|August 21, 2023
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045Yoo-Na Kim, Je-Gun Joung, Eunhyang Park, et al.
Pageof 54